StockData
Biofrontera Inc. logo

Biofrontera Inc. (BFRIW) stock

BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)

Close on Oct 30, 2026Market cap $12.96MP/E –Yield –

Biofrontera operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Biofrontera's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.93M. For fiscal 2025 it was -$13.36M. The highest annual figure on record is -$10.27M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.36M–
FY2024Dec 31, 2024-$10.27M–
FY2023Dec 31, 2023-$24.90M–
FY2022Dec 31, 2022-$16.20M–
FY2021Dec 31, 2021-$26.72M–
FY2020Dec 31, 2020-$12.37M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.66M–
Q1 FY2026Mar 31, 2026-$70.00K–
Q4 FY2025Dec 31, 2025-$2.38M–
Q3 FY2025Sep 30, 2025-$3.82M–
Q2 FY2025Jun 30, 2025-$3.05M–
Q1 FY2025Mar 31, 2025-$4.12M–
Q4 FY2024Dec 31, 2024-$1.02M–
Q3 FY2024Sep 30, 2024-$1.21M–
Q2 FY2024Jun 30, 2024-$4.72M–
Q1 FY2024Mar 31, 2024-$3.33M–
Q4 FY2023Dec 31, 2023-$8.87M–
Q3 FY2023Sep 30, 2023-$2.00M–
Q2 FY2023Jun 30, 2023-$10.34M-8368.8%
Q1 FY2023Mar 31, 2023-$3.69M–
Q4 FY2022Dec 31, 2022-$8.27M–
Q3 FY2022Sep 30, 2022-$5.94M–
Q2 FY2022Jun 30, 2022$125.00K–
Q1 FY2022Mar 31, 2022-$2.11M–
Q4 FY2021Dec 31, 2021-$20.99M–
Q3 FY2021Sep 30, 2021-$1.22M–
Q2 FY2021Jun 30, 2021-$1.07M–
Q1 FY2021Mar 31, 2021-$3.44M–
Q4 FY2020Dec 31, 2020-$663.00K–

More Biofrontera figures